• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肽类血管紧张素II受体亚型特异性配体的功能研究:杜普753(AII-1)和PD123177(AII-2)。

Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).

作者信息

Wong P C, Hart S D, Zaspel A M, Chiu A T, Ardecky R J, Smith R D, Timmermans P B

机构信息

Medical Products Department, E.I. du Pont de Nemours & Company, Wilmington, Delaware.

出版信息

J Pharmacol Exp Ther. 1990 Nov;255(2):584-92.

PMID:2243344
Abstract

DuP 753 and PD123177 are two nonpeptide angiotensin II (AII)-specific ligands, which show high affinities for two respective and distinct subtypes of AII binding sites, i.e., AII-1 and AII-2 sites, respectively, in the rat adrenal gland, brain and uterus. The objective of this study is to identify the functions of these subtype binding sites in the adrenal, sympathetic ganglia, brain and vascular smooth muscle. In conscious rats, DuP 753 at 1, 3 and 10 mg/kg i.v. but not PD123177 at 30 and 100 mg/kg i.v. inhibited the AII-induced aldosterone increase. In the isolated perfused rat adrenal gland, DuP 753 at 10(-6) and 10(-4) M but not PD123177 at 10(-3) M blocked the AII-induced epinephrine secretion. In control and chemically sympathectomized pithed rats, the pressor and tachycardiac responses to AII were blocked by DuP 753 at 10 mg/kg i.v. but not by PD123177 at 100 mg/kg i.v. In conscious rats, DuP 753 at 10 mg/kg s.c. but not PD123177 at 100 mg/kg s.c. inhibited the AII-induced water drinking. In the rabbit aorta, DuP 753 at 10(-6) M but not PD123177 at 10(-4) M inhibited the contractile effect of AII. In conscious renal artery-ligated hypertensive rats, DuP 753 but not PD123177 at 0.1 to 10 mg/kg i.v. lowered blood pressure. In summary, a function of the PD123177-sensitive AII binding site (AII-2) has not yet been identified. However, the DuP 753-sensitive site (AII-1) appears to mediate the AII-induced responses such as adrenal aldosterone and catecholamine secretion, release of catecholamine from sympathetic ganglia, drinking and vasoconstriction.

摘要

DuP 753和PD123177是两种非肽类血管紧张素II(AII)特异性配体,它们分别对大鼠肾上腺、脑和子宫中两种各自不同且独特的AII结合位点亚型,即AII-1和AII-2位点,表现出高亲和力。本研究的目的是确定这些亚型结合位点在肾上腺、交感神经节、脑和血管平滑肌中的功能。在清醒大鼠中,静脉注射1、3和10 mg/kg的DuP 753可抑制AII诱导的醛固酮增加,而静脉注射30和100 mg/kg的PD123177则无此作用。在离体灌注的大鼠肾上腺中,10^(-6)和10^(-4) M的DuP 753可阻断AII诱导的肾上腺素分泌,而10^(-3) M的PD123177则无此作用。在对照和化学去交感神经的脊髓麻醉大鼠中,静脉注射10 mg/kg的DuP 753可阻断对AII的升压和心动过速反应,而静脉注射100 mg/kg的PD123177则无此作用。在清醒大鼠中,皮下注射10 mg/kg的DuP 753可抑制AII诱导的饮水,而皮下注射100 mg/kg的PD123177则无此作用。在兔主动脉中,10^(-6) M的DuP 753可抑制AII的收缩作用,而l0^(-4) M的PD123177则无此作用。在清醒肾动脉结扎的高血压大鼠中,静脉注射0.1至10 mg/kg的DuP 753可降低血压,而PD123177则无此作用。总之,尚未确定PD123177敏感的AII结合位点(AII-2)的功能。然而,DuP 753敏感位点(AII-1)似乎介导了AII诱导的反应,如肾上腺醛固酮和儿茶酚胺分泌、交感神经节释放儿茶酚胺、饮水和血管收缩。

相似文献

1
Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).非肽类血管紧张素II受体亚型特异性配体的功能研究:杜普753(AII-1)和PD123177(AII-2)。
J Pharmacol Exp Ther. 1990 Nov;255(2):584-92.
2
Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.杜普532(一种选择性非竞争性AT1受体拮抗剂)的药理学
J Pharmacol Exp Ther. 1991 Nov;259(2):861-70.
3
Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells.血管紧张素II - 1受体介导大鼠主动脉平滑肌细胞的血管收缩和肥大反应。
Receptor. 1991;1(3):133-40.
4
Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.非肽类血管紧张素II受体拮抗剂:EXP3892的不可逾越性血管紧张素II拮抗作用可被可逾越性拮抗剂DuP 753逆转。
J Pharmacol Exp Ther. 1991 Jul 1;258(1):49-57.
5
Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.非肽类血管紧张素II受体拮抗剂。VIII. 口服活性抗高血压药物DuP 753所表现出的功能性拮抗作用的特征。
J Pharmacol Exp Ther. 1990 Feb;252(2):719-25.
6
Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.非肽类血管紧张素II受体拮抗剂。IX. 口服活性抗高血压药物DuP 753对大鼠的抗高血压活性。
J Pharmacol Exp Ther. 1990 Feb;252(2):726-32.
7
Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart.心脏血管紧张素受体:选择性血管紧张素II受体拮抗剂DUP 753和PD 121981对兔心脏的作用。
J Pharmacol Exp Ther. 1992 Jun;261(3):931-5.
8
The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.血管紧张素II受体拮抗剂DuP 753的降压作用可能并非仅仅归因于血管紧张素II受体拮抗。
J Pharmacol Exp Ther. 1992 Aug;262(2):595-601.
9
Comparison of inhibitory potency by nonpeptide angiotensin II receptor antagonists PD123177 and DuP 753 on proximal nephron and renal transport.非肽类血管紧张素II受体拮抗剂PD123177和DuP 753对近端肾单位及肾脏转运的抑制效能比较
J Pharmacol Exp Ther. 1991 Nov;259(2):687-91.
10
Subclasses of angiotensin II binding sites and their functional significance.血管紧张素II结合位点的亚类及其功能意义。
Mol Pharmacol. 1990 Sep;38(3):370-7.

引用本文的文献

1
Immunolocalization of the AT-1R Ang II Receptor in Human Kidney Cancer.人肾癌中 AT-1R 血管紧张素 II 受体的免疫定位。
Biomolecules. 2023 Jul 28;13(8):1181. doi: 10.3390/biom13081181.
2
Angiotensin II AT2 Receptors Contribute to Regulate the Sympathoadrenal and Hormonal Reaction to Stress Stimuli.血管紧张素 II AT2 受体有助于调节应激刺激的交感肾上腺和激素反应。
Cell Mol Neurobiol. 2018 Jan;38(1):85-108. doi: 10.1007/s10571-017-0533-x. Epub 2017 Sep 7.
3
New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D.
肾素-血管紧张素系统的新成分:阿拉曼丁和 MAS 相关 G 蛋白偶联受体 D。
Curr Hypertens Rep. 2014 Jun;16(6):433. doi: 10.1007/s11906-014-0433-0.
4
Influence of Fimasartan (a Novel AT(1) Receptor Blocker) on Catecholamine Release in the Adrenal Medulla of Spontaneously Hypertensive Rats.新型血管紧张素Ⅱ受体拮抗剂 Fimasartan 对自发性高血压大鼠肾上腺髓质儿茶酚胺释放的影响。
Korean J Physiol Pharmacol. 2013 Feb;17(1):99-109. doi: 10.4196/kjpp.2013.17.1.99. Epub 2013 Feb 14.
5
The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.脑肾素-血管紧张素系统:多种功能及对 CNS 疾病的影响。
Pflugers Arch. 2013 Jan;465(1):133-51. doi: 10.1007/s00424-012-1102-2. Epub 2012 Apr 26.
6
Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).肾素血管紧张素系统的进展集中在血管紧张素转换酶2和血管紧张素-(1-7)上。
Adv Pharmacol. 2010;59:197-233. doi: 10.1016/S1054-3589(10)59007-0.
7
Inhibitory effects of olmesartan on catecholamine secretion from the perfused rat adrenal medulla.奥美沙坦对灌流大鼠肾上腺髓质儿茶酚胺分泌的抑制作用。
Korean J Physiol Pharmacol. 2010 Aug;14(4):241-8. doi: 10.4196/kjpp.2010.14.4.241. Epub 2010 Aug 31.
8
Suggestive evidence of a vesicle-mediated mode of cell degranulation in chromaffin cells. A high-resolution scanning electron microscopy investigation.提示细胞脱颗粒的小泡介导模式的证据。高分辨率扫描电子显微镜研究。
J Anat. 2010 Apr;216(4):518-24. doi: 10.1111/j.1469-7580.2009.01198.x. Epub 2010 Jan 28.
9
Effects of losartan on catecholamine release in the isolated rat adrenal gland.氯沙坦对离体大鼠肾上腺儿茶酚胺释放的影响。
Korean J Physiol Pharmacol. 2009 Aug;13(4):327-35. doi: 10.4196/kjpp.2009.13.4.327. Epub 2009 Aug 31.
10
A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH.外周给药的中枢作用血管紧张素 II AT2 拮抗剂可选择性增加脑 AT1 受体,并降低脑酪氨酸羟化酶转录、垂体加压素和促肾上腺皮质激素。
Brain Res. 2009 Jan 23;1250:130-40. doi: 10.1016/j.brainres.2008.11.006. Epub 2008 Nov 12.